| CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) (NCT02365714) | Georgetown University | 2015-02-01 |
| Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer (NCT04729647) | Kahramanmaras Sutcu Imam University | 2015-02-01 |
| Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer (NCT02520063) | University of Alabama at Birmingham | 2015-02-01 |
| Nutrition, Physical Activity, and Cognition in Breast Cancer Survivors (NCT02591316) | Texas State University, San Marcos | 2015-02-01 |
| Node Negative, Invasive Breast Cancer Single Fraction IOERT (NCT02370797) | Avera McKennan Hospital & University Health Center | 2015-02-01 |
| Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer (NCT02127073) | Montefiore Medical Center | 2015-01-30 |
| Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial. (NCT02240472) | Karolinska Institutet | 2015-01-27 |
| Mindfulness Based Couples Therapy (NCT02349217) | M.D. Anderson Cancer Center | 2015-01-23 |
| Theory-based Training to Promote Breast Cancer Screening (NCT04225741) | Inonu University | 2015-01-22 |
| A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer (NCT02203513) | National Cancer Institute (NCI) | 2015-01-20 |
| Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer (NCT02287675) | Kettering Health Network | 2015-01-19 |
| Unidas Por Vida y Salud: Increasing Breast and Cervical Cancer Screening in El Paso (NCT04397744) | The University of Texas Health Science Center, Houston | 2015-01-16 |
| An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer (NCT02286362) | Hoffmann-La Roche | 2015-01-14 |
| Vaccination of High Risk Breast Cancer Patients (NCT02229084) | University of Arkansas | 2015-01-14 |
| Involvement of the Inositol-trisphosphate Receptor in Invasive or Migratory-type Breast Cancers (NCT03107234) | Centre Hospitalier Universitaire, Amiens | 2015-01-13 |
| Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy (NCT02204098) | Washington University School of Medicine | 2015-01-07 |
| Effects of Mobile Game on Life Quality of Cancer Patients (NCT03205969) | Chung-Ang University Hospital | 2015-01-05 |
| An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol (NCT06374745) | University Hospital, Basel, Switzerland | 2015-01-02 |
| Evaluation of Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System (NCT02155075) | Real Imaging Ltd. | 2015-01-01 |
| Circulating Tumor DNA Exposure in Peripheral Blood (NCT03517332) | Quantgene Inc. | 2015-01-01 |
| Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients (NCT02765373) | Chinese Academy of Medical Sciences | 2015-01-01 |
| Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound. (NCT02324894) | Brugmann University Hospital | 2015-01-01 |
| Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status (NCT02339532) | UNICANCER | 2015-01-01 |
| Multi-Parametric Assessment of Breast Lymphedema (NCT02724514) | University Health Network, Toronto | 2015-01-01 |
| Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer (NCT02651142) | Shandong University | 2015-01-01 |
| Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer (NCT04098926) | University Hospital, Ghent | 2015-01-01 |
| Dual Anti-HER2 Therapy (Lapatinib and Trastuzumab) Plus Chemotherapy in HER2-positive MBC (NCT04001634) | Fudan University | 2015-01-01 |
| Cancer Prevention in Women With a BRCA Mutation (NCT02225015) | Women's College Hospital | 2015-01-01 |
| Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer (NCT03221881) | Hebei Medical University Fourth Hospital | 2015-01-01 |
| A Culturally Sensitive Social Support Intervention (NCT02946697) | M.D. Anderson Cancer Center | 2015-01-01 |
| T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA (NCT02326974) | Dana-Farber Cancer Institute | 2015-01-01 |
| Genetic Alteration After Systemic Treatment in Breast Cancer (NCT02591966) | Samsung Medical Center | 2015-01-01 |
| A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer (NCT02296801) | NSABP Foundation Inc | 2015-01-01 |
| Dose Dense Chemotherapy With Lipegfilgrastim Support in Early Breast Cancer (NCT02527317) | Beaumont Hospital | 2015-01-01 |
| Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging (NCT02510456) | Boston Medical Center | 2015-01-01 |
| Association of Breast Reconstruction Method With Long-term Risk of Psychiatric Disorders (NCT06981689) | Samsung Medical Center | 2015-01-01 |
| SentiMag® Intraoperative Comparison in Breast Cancer (NCT02336737) | Endomagnetics Inc | 2015-01-01 |
| Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients (NCT02348281) | Fudan University | 2015-01-01 |
| An Interactive Empowerment Tool for Breast Cancer Patients (NCT02312700) | University of Milan | 2015-01-01 |
| Percutaneous Irreversible Electroportion for Unresectable Breast Cancer (NCT02340858) | Fuda Cancer Hospital, Guangzhou | 2015-01-01 |
| Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC) (NCT02341911) | Fudan University | 2015-01-01 |
| Inpatient Screening Mammography for Non-adherent and High Risk Women (NCT04164251) | Johns Hopkins University | 2015-01-01 |
| Brief Behavioral Intervention for Insomnia During Chemotherapy (NCT02165839) | Stanford University | 2015-01-01 |
| Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer (NCT04792346) | Regina Elena Cancer Institute | 2015-01-01 |
| Relational and Emotional Mechanisms of a Supportive-expressive Group Intervention in Breast Cancer (NCT02934815) | Universidade do Porto | 2015-01-01 |
| A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer (NCT01823835) | Genentech, Inc. | 2014-12-29 |
| Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment (NCT02326857) | National Cancer Institute (NCI) | 2014-12-23 |
| Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer (NCT02410044) | iOMEDICO AG | 2014-12-23 |
| Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer (NCT02291913) | SCRI Development Innovations, LLC | 2014-12-18 |
| Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer (NCT02250118) | Institut Curie | 2014-12-09 |
| Chemotherapy Induced Peripheral Neuropathy. Could Physical Therapy Help Treat Symptoms? (NCT02239601) | CancerCare Manitoba | 2014-12-01 |
| Post-Mastectomy Surveillance to Detect Recurrence in Breast Cancer Patients (NCT02688725) | Providence Health & Services | 2014-12-01 |
| hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse (NCT02960594) | Inovio Pharmaceuticals | 2014-12-01 |
| Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis (NCT02336750) | Fudan University | 2014-12-01 |
| Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis (NCT02560311) | University of Zurich | 2014-12-01 |
| Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer (NCT02344940) | Shanghai Jiao Tong University School of Medicine | 2014-12-01 |
| Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid (NCT02274623) | OPKO Health, Inc. | 2014-12-01 |
| HER2-Peptide Vaccination of Patients With Solid Tumors (NCT02276300) | Technical University of Munich | 2014-12-01 |
| A Clinical Research of CAR T Cells Targeting CEA Positive Cancer (NCT02349724) | Southwest Hospital, China | 2014-12-01 |
| Tomosynthesis Versus Digital Mammography in a Population-based Screening Program (NCT02590315) | Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte | 2014-12-01 |
| Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) (NCT02331251) | Western Regional Medical Center | 2014-12-01 |
| Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer (NCT02404844) | University Hospital, Essen | 2014-12-01 |
| Optimizing the Care Pathways of Patients Treated for Operable Breast. (NCT02813317) | Institut Curie | 2014-12-01 |
| Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score (NCT02236572) | Yale University | 2014-11-29 |
| Thoracic Spinal Anesthesia in Awake Breast Surgery (NCT03319511) | Alaa Mazy | 2014-11-24 |
| Yoga Practice for Breast or Ovarian Cancer Patients (NCT02305498) | Memorial Sloan Kettering Cancer Center | 2014-11-24 |
| Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy: (NCT02281149) | Centre Oscar Lambret | 2014-11-18 |
| A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI) (NCT02273973) | Genentech, Inc. | 2014-11-12 |
| Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy (NCT02379988) | University of Arizona | 2014-11-06 |
| A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer (NCT02246621) | Eli Lilly and Company | 2014-11-06 |
| Brazilian Randomized Study - Impact of MRI for Breast Cancer (NCT02798796) | University of Sao Paulo General Hospital | 2014-11-01 |
| REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity) (NCT02079272) | Sophie JACOB | 2014-11-01 |
| Oocyte Recovery During Tamoxifen Adjuvant Therapy (NCT02355600) | Instituto de Investigacion Sanitaria La Fe | 2014-11-01 |
| MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study (NCT02301767) | Memorial Sloan Kettering Cancer Center | 2014-11-01 |
| Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer (NCT02275871) | Beth Israel Deaconess Medical Center | 2014-11-01 |
| Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen (NCT02285179) | The Netherlands Cancer Institute | 2014-11-01 |
| Outcome of Pregnancy and Breast Cancer (NCT02774915) | National Guard Health Affairs | 2014-11-01 |
| Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients (NCT03606616) | Peking University People's Hospital | 2014-11-01 |
| Whole Breast RT on Prone Position in Korean Women (NCT02231112) | Samsung Medical Center | 2014-11-01 |
| Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases (NCT02260531) | Dana-Farber Cancer Institute | 2014-11-01 |
| A Prospective Study on Effect of Systemic Adjuvant Therapy on Cognitive and Brain Function of Breast Cancer Patients (NCT02078531) | National University Hospital, Singapore | 2014-10-29 |
| Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial (NCT02276885) | NYU Langone Health | 2014-10-28 |
| Biomarkers of Neuropathic Pain in Women Treated for Breast Cancer (NCT02487524) | Helsinki University Central Hospital | 2014-10-28 |
| Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies (NCT02223052) | Celgene | 2014-10-27 |
| Genotype and Phenotype in Early Onset Breast Cancer in Young Women on the Two Shores of the Mediterranean Sea (NCT02541188) | University Hospital, Montpellier | 2014-10-02 |
| TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer (NCT02290782) | Universitätsmedizin Mannheim | 2014-10-01 |
| Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer (NCT02318901) | Western Regional Medical Center | 2014-10-01 |
| FAST MRI Study in Breast Cancer Survivors (NCT02244593) | Ottawa Hospital Research Institute | 2014-10-01 |
| Dead Space Closure With Quilting Suture Versus Conventional Closure With Drainage (NCT02263651) | University Hospital, Tours | 2014-10-01 |
| Prevention of Paclitaxel Neuropathy With Cryotherapy (NCT02230319) | Medical Oncology & Hematology Associates of Northern Virginia | 2014-10-01 |
| Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial (NCT02256670) | Yale University | 2014-10-01 |
| Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial (NCT02200705) | IceCure Medical Ltd. | 2014-10-01 |
| Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer Subjects (NCT02187289) | AHS Cancer Control Alberta | 2014-10-01 |
| Prevalence, Severity and Determinants of Cancer-related Fatigue (CRF) in Asian Breast Cancer Patients (NCT02304640) | National University of Singapore | 2014-10-01 |
| 18-F-Fluoroacetate as PET Imaging Agent (NCT01320787) | M.D. Anderson Cancer Center | 2014-10-01 |
| Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older (NCT02328313) | UNC Lineberger Comprehensive Cancer Center | 2014-10-01 |
| Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients (NCT02297698) | Cancer Insight, LLC | 2014-10-01 |
| Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer (NCT02934828) | Chinese Academy of Medical Sciences | 2014-10-01 |
| HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer (NCT02063724) | H. Lee Moffitt Cancer Center and Research Institute | 2014-10-01 |
| Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart (NCT02052102) | AHS Cancer Control Alberta | 2014-10-01 |